Emerging Preclinical Models of Cancer and Immuno-oncology for Drug Development; Focus on Novel Humanized Mouse Models

Presented by Amy Wesa, Director IO R&D

Read about:

  • Champions Oncology humanized mouse models and mouse strain selection
  • A novel PBMC Immunograft Platform
  • Other Immuno-Oncology Platforms